Literature DB >> 3946757

The desmoid syndrome. New aspects in the cause, pathogenesis and treatment of the desmoid tumor.

J J Reitamo, T M Scheinin, P Häyry.   

Abstract

Based on a detailed clinical and laboratory investigation of 89 patients with histologically verified desmoid tumor and the pertinent medical literature, we have reviewed the etiologic factors, clinical characteristics, and results of treatment of this rare disorder. The incidence of the tumor in the Finnish population is low, 2.4 to 4.3 new cases per 10(6) inhabitants per year. The age distribution profile demonstrated four distinct peak periods: the juvenile period, the fertile period, the middle-age period and the old-age period. The juvenile desmoid tumor is an extraabdominal tumor found in young girls, the fertile variety is an abdominal tumor found in women, the middle age variety is also overwhelmingly abdominal but the sex ratio approaches equality, whereas in the old age group, both abdominal and extraabdominal tumors are equally frequent and the sex ratio is equal. In all male patients, the growth rate was low. A low growth rate was also recorded in young girls. A growth rate of twice that speed was seen in fertile women and four times that speed in the middle age group. In the old age group, a low growth rate, equal to that of male patients, was a rule. The fertile female patients with desmoid tumor had a significant predisposition to estrogen dominance and deviation from progesterone dominance. The direct relationship of the growth rate to the level of endogenous estrogen in the female patients and the demonstration of significant amounts of estradiol but not progesterone receptors in the tumor cytosol further suggest that the growth rate of desmoid tumor is regulated by steroid sex hormones. A significant number of patients with an abdominal desmoid tumor had a history of surgical trauma in the region of subsequent tumor growth. A very high number of the patients demonstrated multiple minor malformations of the bony skeleton. An increased frequency of these malformations was also recorded in the families of the patients and the distribution of the malformations among the family members was compatible with an autosomally dominant pattern of inheritance. After operation, the frequency of recurrence was not statistically different, regardless of whether the tumor was completely removed or not. A combination of operation and radiotherapy did not reduce the frequency of recurrences; in fact, it doubled it.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3946757     DOI: 10.1016/0002-9610(86)90076-0

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  91 in total

1.  Mesenteric fibromatosis of the ileocolic area: a case report.

Authors:  Cemil Caliskan; Mustafa A Korkut
Journal:  Indian J Surg       Date:  2010-11-16       Impact factor: 0.656

2.  Mesenteric desmoid tumour masquerading as a fat-containing cystic mass.

Authors:  C H Tan; U Pua; K H Liau; H Y Lee
Journal:  Br J Radiol       Date:  2010-10       Impact factor: 3.039

3.  Long-term outcome of sporadic and FAP-associated desmoid tumors treated with high-dose selective estrogen receptor modulators and sulindac: a single-center long-term observational study in 134 patients.

Authors:  Daniel Robert Quast; Ralph Schneider; Emanuel Burdzik; Steffen Hoppe; Gabriela Möslein
Journal:  Fam Cancer       Date:  2016-01       Impact factor: 2.375

4.  [Aggressive fibromatosis in the jaw and facial region with bone involvement. A review].

Authors:  L Seper; P Hoppe; B Kruse-Lösler; A Büchter; U Joos; J Kleinheinz
Journal:  Mund Kiefer Gesichtschir       Date:  2005-11

5.  Intracranial aggressive fibromatosis presenting as panhypopituitarism and diabetes insipidus.

Authors:  A Gursoy; M Cesur; B Aktaş; G Utkan; V Tonyukuk Gedik; Mf Erdogan; N Kamel
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

Review 6.  Radiation therapy for the treatment of benign vascular, skeletal and soft tissue diseases.

Authors:  A Montero Luis; R Hernanz de Lucas; A Hervás Morón; E Fernández Lizarbe; S Sancho García; C Vallejo Ocaña; A Polo Rubio; A Ramos Aguerri
Journal:  Clin Transl Oncol       Date:  2008-06       Impact factor: 3.405

Review 7.  Children's Oncology Group's 2013 blueprint for research: Soft tissue sarcomas.

Authors:  Douglas S Hawkins; Sheri L Spunt; Stephen X Skapek
Journal:  Pediatr Blood Cancer       Date:  2012-12-19       Impact factor: 3.167

8.  Inherited colorectal cancer syndromes.

Authors:  C Neal Ellis
Journal:  Clin Colon Rectal Surg       Date:  2005-08

9.  Colonic adenomatous polyposis syndromes: clinical management.

Authors:  C Neal Ellis
Journal:  Clin Colon Rectal Surg       Date:  2008-11

10.  [Extra-abdominal desmoid tumors. Case report and literature review].

Authors:  J Ridders; A Ernst; I Todt; R O Seidl
Journal:  HNO       Date:  2005-07       Impact factor: 1.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.